NLM Logo

Antineoplastic Agents, Hormonal MeSH Descriptor Data 2022


MeSH Heading
Antineoplastic Agents, Hormonal
Tree Number(s)
D27.505.954.248.169
Unique ID
D018931
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D018931
Annotation
consider also NEOPLASMS, HORMONE-DEPENDENT /‌drug ther
Scope Note
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
Entry Version
ANTINEOPL AGENTS HORMONAL
Entry Term(s)
Antineoplastic Drugs, Hormonal
Antineoplastic Hormonal Agents
Antineoplastic Hormonal Drugs
Antineoplastics, Hormonal
Hormonal Agents, Antineoplastic
Hormonal Antineoplastic Agents
Hormonal Antineoplastic Drugs
Hormonal Antineoplastics
Registry Number
0
Previous Indexing
Antineoplastic Agents (1966-1995)
Public MeSH Note
96
History Note
96
Date Established
1996/01/01
Date of Entry
1995/05/26
Revision Date
2005/06/30
Antineoplastic Agents, Hormonal Preferred
page delivered in 0.257s